Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Prospective, Open-label, Parallel Time-cohort Study to Evaluate the Immune Responses and Safety ofSubunit Influenza Vaccine in Healthy Adults

NCT07854392 is registered in ClinicalTrials.gov with Ab&B Bio-tech Co., Ltd.JS as lead sponsor.

NCT NCT07854392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07854392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Prospective, Open-label, Parallel Time-cohort Study to Evaluate the Immune Responses and Safety ofSubunit Influenza Vaccine in Healthy Adults
Lead sponsor
Ab&B Bio-tech Co., Ltd.JS
Phase
Phase 4
Overall status
Recruiting
Start date
October 11, 2026
Completion date
October 11, 2027
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza